CD5 is dissociated from the B-cell receptor in B cells from bovine leukemia virus-infected, persistently lymphocytotic cattle: Consequences to B-cell receptor-mediated apoptosis

被引:31
作者
Cantor, GH [1 ]
Pritchard, SM
Dequiedt, F
Willems, L
Kettmann, R
Davis, WC
机构
[1] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA
[2] Fac Agron, Dept Appl Biochem & Biol, Mol Biol & Anim Physiol Unit, B-5030 Gembloux, Belgium
关键词
D O I
10.1128/JVI.75.4.1689-1696.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Bovine leukemia virus (BLV), a retrovirus related to human T-cell leukemia virus types 1 and 2, can induce persistent nonneoplastic expansion of the CD5(+) B-cell population, termed persistent lymphocytosis (PL). As in human CD5(+) B cells, we report here that CD5,vas physically associated with the B-cell receptor (BCR) in normal bovine CD5(+) B cells. In contrast, in CD5(+) B cells from BLV-infected PL cattle, CD5 was dissociated from the BCR. In B cells from PL cattle, apoptosis decreased when cells were stimulated with antibody to surface immunoglobulin M (sIgM), while in B cells from uninfected cattle, apoptosis increased after sIgM stimulation. The functional significance of the CDS-BCR association was suggested by experimental dissociation of the CDS-BCR interaction by cross-linking of CD5. This caused CD5(+) E cells from uninfected animals to decrease apoptosis when stimulated with anti-sIgM. In contrast, in CD5(+) B cells from PL animals, in which CD5 was already dissociated from the BCR, there was no statistically significant change in apoptosis when CD5 was cross-linked and the cells were stimulated,vith anti-sIgM. Disruption of CD5-BCR interactions and subsequent decreased apoptosis and increased survival in antigenically stimulated B cells may be a mechanism of BLV-induced FL.
引用
收藏
页码:1689 / 1696
页数:8
相关论文
共 48 条
[21]  
INTERNATIONAL Committee on Bovine Leukosis, 1968, JNCI, V41, P243
[22]   Anti-CD5 extends the proliferative response of human CD5(+) B cells activated with anti-IgM and interleukin-2 [J].
Jamin, C ;
LeCorre, R ;
Lydyard, PM ;
Youinou, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (01) :57-62
[23]   CD5 IS ASSOCIATED WITH THE HUMAN B-CELL ANTIGEN RECEPTOR COMPLEX [J].
LANKESTER, AC ;
VANSCHIJNDEL, GMW ;
CORDELL, JL ;
VANNOESEL, CJM ;
VANLIER, RAW .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (04) :812-816
[24]  
LETESSON JJ, 1985, ANN MED VET, V129, P131
[25]  
MASON DY, 1991, J IMMUNOL, V147, P2474
[26]  
MATHEISE JP, 1992, LEUKEMIA, V6, P304
[27]   PHYSICAL ASSOCIATION OF CD5 AND THE T-CELL RECEPTOR CD3 ANTIGEN COMPLEX ON THE SURFACE OF HUMAN T-LYMPHOCYTES [J].
OSMAN, N ;
LAZAROVITS, AI ;
CRUMPTON, MJ .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (05) :1173-1176
[28]  
Perez-Villar JJ, 1999, MOL CELL BIOL, V19, P2903
[29]  
Pers JO, 1998, EUR J IMMUNOL, V28, P4170, DOI 10.1002/(SICI)1521-4141(199812)28:12<4170::AID-IMMU4170>3.0.CO
[30]  
2-O